Novavax says it has begun enrolling participants in first human study of its coronavirus vaccine
- The company says it’ll test vaccine safety, immune responses in about 130 healthy adults in Australia
- expects initial results in July
- to expand study to US if promising
The big problem I see here is how to begin the pump and dump scheme if NASDAQ is closed for the holiday?
—
Novavax is a US vaccine development company.